InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Telman Deborah H, 董事. Insider active across 3 companies, notably AtriCure, Inc.. Aggregated, 28 reports have been logged. Activity tracked since 15 June 2021. The latest transaction was disclosed on 12 November 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Telman Deborah H
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报28 总计
17,181 股@ US$75.1283.2% 占其流量Common StockSEC:0001860008-25-000009:0
515 股Common StockSEC:0001860008-25-000007:0
1,315 股Common StockSEC:0001860008-25-000005:0
514 股Common StockSEC:0001127602-25-019654:0
1,313 股Common StockSEC:0001127602-25-017337:0
5,401 股0Common StockSEC:0001323885-25-000059:0
514 股Common StockSEC:0001127602-25-012668:0
3,343 股Common StockSEC:0001127602-25-009290:0
12,371 股0Common StockSEC:0001127602-25-003389:0
515 股Common StockSEC:0001127602-25-002030:0
639 股Common StockSEC:0001127602-24-029181:0
514 股Common StockSEC:0001127602-24-026017:0
639 股Common StockSEC:0001127602-24-023825:0
2,917 股@ US$76.5191.2% 占其流量Common StockSEC:0001127602-24-021048:0
638 股Common StockSEC:0001127602-24-018411:0
7,788 股0Common StockSEC:0001323885-24-000080:0
515 股Common StockSEC:0001127602-24-013462:0
2,555 股Common StockSEC:0001127602-24-009742:0
4,646 股0Common StockSEC:0001127602-24-003028:0
514 股Common StockSEC:0001127602-24-002300:0
514 股Common StockSEC:0001127602-23-026281:0
8,231 股Common StockSEC:0001127602-23-021338:0
3,186 股0Common StockSEC:0001323885-23-000061:0
376 股@ US$56.38058.8% 占其流量Common StockSEC:0001127602-23-006757:0
3,564 股0Common StockSEC:0001323885-22-000073:0
28 条申报中的 25 条
About Telman Deborah H
Telman Deborah H is an administrateur, with 28 filings in total. Among the sampled recent filings, the most common transaction type is option exercise, and the observed period runs from 2021-06-17 to 2025-11-13. The companies mentioned are Gilead Sciences, INC., AtriCure, Inc. and Organon & Co., and the stated buy and sell amounts are EUR 0.
